The right formula

editorial image

A COMPANY is taking on 25 workers as it gets ready to re-open a plant near Hartlepool.

TryggPharma of Norway has sealed a £14m deal to take on the former facilities of Lundbeck Pharmaceuticals (Denmark) at Seal Sands.

The site had won awards before it was forced to close during the recession, with Lundbeck deciding to consolidate production from three sites to two in Europe.

Since then the site has been up for sale with former site manager Peter Trickett and the North East Process Industry Cluster (NEPIC) working together to promote the facility and attract new owners.

TryggPharma’s vice president of engineering Peter Harper said: “We are very impressed with the facility and the potential of the Teesside area to support the growth of our business going forward.

“The unit is relatively new and has received permitting to make active pharmaceutical ingredients in the past. Its equipment and technology are a good fit for our processes and the local infrastructure is excellent.”

He said the unit was based in an “international location that is easy to access from Norway, Europe, and our customers around the world”.

On re-opening, the unit is expected to employ 25 people within 12 months to restart facilities.

TryggPharma’s chief executive Aaron Kramer said his company was seeing significant growth in its specialist field of products based on omega-3.

“In addition to getting production up and running as soon as we can, there is commitment to invest and expand into the future on Teesside.

“This of course means even more local jobs at the Teesside unit,” he added.

NEPIC chief executive Stan Higgins said: “The whole process industry in the North-East of England will be celebrating this news. It’s great for Teesside and for the pharmaceutical sector in particular to see another of our units back into operation.

“We have worked hard around the world to keep the profile of this facility in the forefront of potential purchaser’s minds.

“It has been a difficult sell as there was no business being left with the plant but it sounds like a perfect fit for the products of TryggPharma, who we welcome into the cluster family here in the region.”